Beaker Is Half Full for Biopharma Investing

Jeff Calcagno of Scale Venture Partners sees reason to be optimistic about the biopharmaceutical sector, even in a recession

1 January 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail